Next 10 |
2024-05-30 12:23:06 ET Roivant Sciences Ltd. (ROIV) Q4 2023 Earnings Conference Call May 30, 2024, 8:00 AM ET Company Participants Abby Beier - Principal, Strategic Finance Matt Gline - Chief Executive Officer Frank Torti - Managing Director, Vant Chair Mayuk...
2024-05-30 07:08:51 ET More on Roivant Sciences Roivant Sciences: Cashing In On Vants And Ventures Roivant Sciences: $7bn Televant Sale Sets It Up For Long-Term Success Roivant announces $1.5B share buyback, positive Phase 2 data Seeking Alpha’s Quant ...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...
2024-05-29 13:50:15 ET More on Roivant Sciences Roivant Sciences: Cashing In On Vants And Ventures Roivant Sciences: $7bn Televant Sale Sets It Up For Long-Term Success Roivant announces $1.5B share buyback, positive Phase 2 data Seeking Alpha’s Quant ...
2024-05-29 10:50:14 ET Major earnings expected before the bell on Thursday include: Best Buy ( BBY ) Canopy Growth ( CGC ) Dollar General ( DG ) Hormel Foods ( HRL ) Royal Bank of Canada ( RY ) Read the full article on Seeking Alpha Fo...
BASEL, Switzerland and LONDON and NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 30, 2024, to report its financial results for the fourth quarter and fiscal year ended March 31...
2024-05-01 10:47:16 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks . Each exhibits...
2024-04-25 10:05:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP returned 6.0% for the First Quarter of 2024. The Fund has annualized returns of 10.0% since inception, compa...
2024-04-24 15:15:35 ET Summary Roivant Sciences sold a subsidiary for $7.1 billion and plans a $1.5 billion stock buyback. Its pipeline includes promising drugs like IMVT-1402, despite some clinical risks. Financially, Roivant is well-capitalized with $6.67 billion in cash aga...
2024-04-24 07:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...
On Wednesday, BuzzFeed Inc (NASDAQ:BZFD) shares gained after former republican Presidential candidate Vivek Ramaswamy took a 7....
On Wednesday, BuzzFeed Inc (NASDAQ:BZFD) shares gained after former republican Presidential candidate Vivek Ramaswamy took a 7....